Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Peter L. Gowland"'
Autor:
Nancy T. Chang, Peter Graepel, Jürg Böni, Dietmar G. Braun, Ruey-Shyan Liou, Huldrych F. Günthard, Peter Grob, Michael S. C. Fung, Jörg Schüpbach, Peter L. Gowland, Ruedi Lüthy
Publikováno v:
Europe PubMed Central
A phase I/IIA clinical trial with the chimeric mouse-human monoclonal antibody CGP 47,439 to the principal neutralization determinant in the V3 region of human immunodeficiency virus type 1 (HIV-1) strain IIIB envelope protein gp120 is reported. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17f8e62a2a8a8e7fdd58f3ff1633e70e
http://doc.rero.ch/record/299229/files/170-6-1384.pdf
http://doc.rero.ch/record/299229/files/170-6-1384.pdf
Publikováno v:
AIDS. 12:2253-2260
The objective was to clarify the relationship between the number of provirus-bearing peripheral blood mononuclear cells (PBMC) and HIV-1 disease progression during the natural history of infection. Twenty-four HIV-1-infected subjects with known seroc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::501280c58dee05bbc9da841325c1f64a
https://doi.org/10.1097/00002030-199817000-00005
https://doi.org/10.1097/00002030-199817000-00005
Autor:
Jörg Schüpbach, Tse Wen Chang, Daniel Gygax, Nancy T. Chang, W. Gordon, Huldrych F. Günthard, Dietmar G. Braun, Ruey-Shyan Liou, Luigi Botta, Michael S. C. Fung, Ruedi Lüthy, Peter L. Gowland
Publikováno v:
Biotherapy. 6:205-215
The pharmacokinetics of mouse V/human C (gamma 1, kappa) chimeric monoclonal antibody CGP 47 439 specific for the principal neutralizing determinant of human immunodeficiency virus type 1 (HIV-1) was studied in patients with stage IV HIV-1 disease in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a4a5995009ecbacc2740fe4d199f3b9
https://doi.org/10.1007/bf01878082
https://doi.org/10.1007/bf01878082